Bio-Techne
TECH
#1902
Rank
NZ$19.18 B
Marketcap
NZ$122.32
Share price
-0.17%
Change (1 day)
32.08%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2026 (TTM): NZ$1.24

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$1.20. In 2025 the company made an earnings per share (EPS) of NZ$0.88 a decrease over its 2024 EPS that were of NZ$1.69.

EPS history for Bio-Techne from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$1.2440.87%
2025NZ$0.88-48%
2024NZ$1.69-29.58%
2023NZ$2.40-14.97%
2022NZ$2.8224.16%
2021NZ$2.2717.98%
2020NZ$1.93-10.94%
2019NZ$2.16101.57%
2018NZ$1.07-16.99%
2017NZ$1.2945.02%
2016NZ$0.89-20.97%
2015NZ$1.13-14.97%
2014NZ$1.33

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$30.80 2,466.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$5.58 364.79%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
NZ$14.47 1,105.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$8.77 630.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.29 174.36%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
NZ-$0.36-129.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ$10.33 760.56%๐Ÿ‡บ๐Ÿ‡ธ USA